viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 2139
tüüp :
ajaleht
uurimisrühmad :
Nancy - University Hospital of Nancy, Department of Pharmacy
Autor :
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
pealkiri :
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
publikatsioon :
EJHP Science ; 12,5: 96-99. 2006
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Acetylsalicylic acid lysinate
8.33 mg/ml
+
Pantoprazole sodium
8 mg/ml
Amiodarone hydrochloride
12.5 mg/ml
+
Amoxicillin sodium / clavulanic acid
10 mg/ml
Amoxicillin sodium / clavulanic acid
10 mg/ml
+
Amiodarone hydrochloride
12.5 mg/ml
Bumetanide
0.5 mg/ml
+
Ofloxacin
5 mg/ml
Cyamemazin
0.2 mg/ml
+
Pantoprazole sodium
8 mg/ml
Midazolam hydrochloride
0.1 mg/ml
+
Pantoprazole sodium
8 mg/ml
Ofloxacin
5 mg/ml
+
Bumetanide
0.5 mg/ml
Pantoprazole sodium
8 mg/ml
+
Acetylsalicylic acid lysinate
8.33 mg/ml
8 mg/ml
+
Cyamemazin
0.2 mg/ml
8 mg/ml
+
Midazolam hydrochloride
0.1 mg/ml
8 mg/ml
+
Vancomycin hydrochloride
40 mg/ml
Rifampicin
6 mg/ml
+
Tramadol hydrochloride
8.33 mg/ml
Tramadol hydrochloride
8.33 mg/ml
+
Rifampicin
6 mg/ml
Vancomycin hydrochloride
40 mg/ml
+
Pantoprazole sodium
8 mg/ml
Mentions Légales